Daniel A. Lichtenstein
Impact in
-
- Antifungal resistance and susceptibility
-
- Ultrasound in Clinical Applications
Papers in
- Oncology 5
- CAR-T cell therapy research 4
-
- Porphyrin Metabolism and Disorders 3
- Heme Oxygenase-1 and Carbon Monoxide 2
- Co-authors
- Amanda Cotter (1 shared paper)Donald C. Vinh (1 shared paper)Donald C. Sheppard (1 shared paper)Christina Gavino (1 shared paper)William D. Foulkes (1 shared paper)Claude Fortin (1 shared paper)Najmeh Alirezaie (1 shared paper)Duncan Lejtenyi (1 shared paper)
- Journals
- Blood Advances (3 papers)Blood (2 papers)Clinical Infectious Diseases (1 paper)Journal of Immunotherapy (1 paper)PLoS neglected tropical diseases (1 paper)
- Partner nations
- United StatesUnited KingdomFrance
In The Last Decade
Daniel A. Lichtenstein
15 papers receiving 338 citations
Peers
Comparison fields: 5 of 62
- Infectious Diseases 86
- Critical Care and Intensive Care Medicine 20
- Immunology 81
- Hematology 35
- Health 22
Countries citing papers authored by Daniel A. Lichtenstein
This map shows the geographic impact of Daniel A. Lichtenstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel A. Lichtenstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel A. Lichtenstein more than expected).
Fields of papers citing papers by Daniel A. Lichtenstein
This network shows the impact of papers produced by Daniel A. Lichtenstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel A. Lichtenstein. The network helps show where Daniel A. Lichtenstein may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel A. Lichtenstein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 123 | |
| 2 | 2021 | 37 | |
| 3 | 2022 | 31 | |
| 4 | 2016 | 28 | |
| 5 | 2020 | 23 | |
| 6 | 2020 | 20 | |
| 7 | Knuckle pads--a forgotten skin condition: report of a case and review of the literature. | 1996 | 19 |
| 8 | 2023 | 17 | |
| 9 | 2017 | 16 | |
| 10 | 2017 | 13 | |
| 11 | 2019 | 7 | |
| 12 | 2017 | 4 | |
| 13 | 2020 | 2 | |
| 14 | 2012 | 1 | |
| 15 | 1998 | 1 | |
| 16 | 2025 | 0 |
About Daniel A. Lichtenstein
Daniel A. Lichtenstein is a scholar working on Oncology, Molecular Biology, Hematology, Critical Care and Intensive Care Medicine and Immunology, having authored 16 papers that have together received 342 indexed citations. Recurring topics across this work include CAR-T cell therapy research (4 papers), Ultrasound in Clinical Applications (3 papers), Porphyrin Metabolism and Disorders (3 papers), Metalloenzymes and iron-sulfur proteins (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Heme Oxygenase-1 and Carbon Monoxide (2 papers), Immune Cell Function and Interaction (2 papers) and Lung Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Infectious Diseases (86 citations), Critical Care and Intensive Care Medicine (20 citations), Immunology (81 citations), Hematology (35 citations) and Health (22 citations). Daniel A. Lichtenstein has collaborated with scholars based in United States, United Kingdom and France. Frequent co-authors include Amanda Cotter, Donald C. Vinh, Donald C. Sheppard, Christina Gavino, William D. Foulkes, Claude Fortin, Najmeh Alirezaie, Duncan Lejtenyi, Jacek Majewski and Marcel A. Behr. Their work appears in journals such as Blood Advances, Blood, Clinical Infectious Diseases, Journal of Immunotherapy and PLoS neglected tropical diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.